Andy Pasternak

Insider Reports History

Entity
Individual
Location
C/O Horizon Therapeutics Plc, Connaught House, 1 St Fl, 1 Burlington Rd, Dublin, Ireland
Signature
/s/ Patrick McIlvenny, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andy Pasternak:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Horizon Therapeutics Public Ltd Co EVP, Chief Strategy Officer Restricted Stock Units (RSU) 23K Jan 4, 2023 Direct
Horizon Therapeutics Public Ltd Co EVP, Chief Strategy Officer Performance Restricted Stock Units (PSUs) 17.5K Dec 27, 2022 Direct
Horizon Therapeutics Public Ltd Co EVP, Chief Strategy Officer Performance Restricted Stock Units (PSU) 5.82K Dec 30, 2022 Direct
Horizon Therapeutics Public Ltd Co EVP, Chief Strategy Officer Ordinary Shares 0 $116.50 Oct 6, 2023 Direct
Horizon Therapeutics Public Ltd Co EVP, Chief Strategy Officer Performance Restricted Stock Units 0 Oct 6, 2023 Direct
Horizon Therapeutics Public Ltd Co EVP, Chief Strategy Officer Restricted Stock Units 0 Oct 6, 2023 Direct
Horizon Therapeutics Public Ltd Co EVP, Chief Strategy Officer Stock Option (Right to Buy) 0 Dec 13, 2022 Direct

Insider Reports Filed by Andy Pasternak

Symbol Company Period Transactions Value $ Form Type Date Filed Role
HZNP Horizon Therapeutics Public Ltd Co Oct 6, 2023 13 -$6.56M 4 Oct 6, 2023 EVP, Chief Strategy Officer
HZNP Horizon Therapeutics Public Ltd Co Jan 17, 2023 1 -$3.07M 4 Jan 18, 2023 EVP, Chief Strategy Officer
HZNP Horizon Therapeutics Public Ltd Co Jan 4, 2023 1 $0 4 Jan 6, 2023 EVP, Chief Strategy Officer
HZNP Horizon Therapeutics Public Ltd Co Dec 30, 2022 10 -$4.47M 4 Jan 4, 2023 EVP, Chief Strategy Officer
HZNP Horizon Therapeutics Public Ltd Co Dec 27, 2022 2 $0 4 Dec 29, 2022 EVP, Chief Strategy Officer
HZNP Horizon Therapeutics Public Ltd Co Dec 13, 2022 4 -$2.71M 4 Dec 14, 2022 EVP, Chief Strategy Officer
HZNP Horizon Therapeutics Public Ltd Co Nov 1, 2022 3 -$348K 4 Nov 2, 2022 EVP and Chief Business Officer
HZNP Horizon Therapeutics Public Ltd Co Jul 29, 2022 2 -$400K 4 Jul 29, 2022 EVP and Chief Business Officer
HZNP Horizon Therapeutics Public Ltd Co Jun 10, 2022 1 -$65K 4 Jun 13, 2022 EVP and Chief Business Officer
HZNP Horizon Therapeutics Public Ltd Co Feb 18, 2022 1 -$124K 4 Feb 18, 2022 EVP and Chief Business Officer
HZNP Horizon Therapeutics Public Ltd Co Jan 4, 2022 11 -$3.01M 4 Jan 6, 2022 EVP and Chief Business Officer
HZNP Horizon Therapeutics Public Ltd Co Dec 7, 2021 1 -$153K 4 Dec 8, 2021 EVP and Chief Business Officer
HZNP Horizon Therapeutics Public Ltd Co Nov 4, 2021 8 -$2.72M 4 Nov 5, 2021 EVP and Chief Business Officer
HZNP Horizon Therapeutics Public Ltd Co Nov 1, 2021 3 -$651K 4 Nov 3, 2021 EVP and Chief Business Officer
HZNP Horizon Therapeutics Public Ltd Co Sep 9, 2021 4 -$1.82M 4 Sep 13, 2021 EVP and Chief Business Officer
HZNP Horizon Therapeutics Public Ltd Co Jul 28, 2021 3 -$395K 4 Jul 30, 2021 EVP and Chief Business Officer